SARA GARCIA OSTREM: Open Payments
NPI 1245608298 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,621 in 37 payments from 11 companies in 2025. Trend: 2023 $1,393 · 2024 $1,044 · 2025 $1,621
Food & beverage: $1,621
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 3 | $421 |
| AstraZeneca Pharmaceuticals LP | 3 | $239 |
| E.R. Squibb & Sons, L.L.C. | 10 | $166 |
| Novo Nordisk Inc | 4 | $166 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $135 |
| Edwards Lifesciences Corporation | 1 | $132 |
| Abbott Laboratories | 1 | $113 |
| Amgen Inc. | 5 | $81 |
| Novartis Pharmaceuticals Corporation | 4 | $80 |
| PFIZER INC. | 3 | $57 |
Products named: Barostim Neo System, CAMZYOS, Wegovy, Kerendia, FARXIGA, SAPIEN 3 Ultra RESILIA, AVEIR, LOKELMA.
Industry payments across TX — which companies pay providers there.
